Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

YOURCARE YOUR PARTNER IN HEALTH CARE SKOVSGAARD AGENTUR ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 2.7% 2.7%   Bankruptcy risk   2.4% 1.3% 8.5% 2.1% 1.1% 2.6% 11.1% 10.8%   Credit score (0-100)   66 82 29 67 85 60 22 23   Credit rating   BBB A BB A A BBB BB BB   Credit limit (kDKK)   0.0 37.4 0.0 0.2 144,446.7 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   1,484 1,729 1.9 1,958 2,398,030 995 0.0 0.0   EBITDA   570 796 0.7 790 1,140,639 -147 0.0 0.0   EBIT   570 778 0.7 790 1,140,639 -147 0.0 0.0   Pre-tax profit (PTP)   481.5 771.5 0.7 771.0 1,132,333.0 -158.3 0.0 0.0   Net earnings   366.8 587.7 0.6 600.0 872,923.0 -124.9 0.0 0.0   Pre-tax profit without non-rec. items   560 771 0.7 771 1,132,333 -158 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   22.8 5.0 0.0 0.0 0.0 0.0 0.0 0.0   Shareholders equity total   776 1,114 1.4 1,228 1,702,128 777 697 697   Interest-bearing liabilities   0.0 192 0.0 1.0 705 351 0.0 0.0   Balance sheet total (assets)   1,629 2,127 2.4 3,030 2,616,040 1,572 697 697   Net Debt   -638 -524 -0.2 -653 -1,176,676 347 -697 -697     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   1,484 1,729 1.9 1,958 2,398,030 995 0.0 0.0   Gross profit growth   20.5% 16.5% -99.9% 105,225.4% 122,373.4% -100.0% -100.0% 0.0%   Employees   0 0 2 2 2 2 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   1,629 2,127 2 3,030 2,616,040 1,572 697 697   Balance sheet change%   9.8% 30.5% -99.9% 124,642.7% 86,238.0% -99.9% -55.6% 0.0%   Added value   570.4 796.2 0.7 790.0 1,140,639.0 -146.5 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -78 -36 -5 0 0 0 0 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 5.0 -1.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   38.4% 45.0% 39.2% 40.3% 47.6% -14.7% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   36.6% 41.4% 0.1% 52.1% 87.2% -0.0% 0.0% 0.0%   ROI %   94.3% 74.5% 0.1% 128.4% 134.0% -0.0% 0.0% 0.0%   ROE %   61.8% 62.2% 0.1% 97.6% 102.5% -0.0% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   47.7% 52.4% 58.9% 40.5% 65.1% 49.4% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -111.8% -65.8% -28.1% -82.7% -103.2% -236.6% 0.0% 0.0%   Gearing %   0.0% 17.2% 0.3% 0.1% 0.0% 45.1% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% 7.2% 0.0% 3,784.9% 2,723.5% 2.2% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   1.4 1.3 1.4 0.9 2.0 0.4 0.0 0.0   Current Ratio   1.9 2.6 2.4 1.7 2.8 2.0 0.0 0.0   Cash and cash equivalent   637.6 715.9 0.2 654.0 1,177,381.0 4.1 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   744.0 1,284.7 1.4 1,212.0 1,685,978.0 761.1 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 0 0 395 570,320 -73 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 0 0 395 570,320 -73 0 0   EBIT / employee   0 0 0 395 570,320 -73 0 0   Net earnings / employee   0 0 0 300 436,462 -62 0 0